QuidelOrtho (QDEL) Change in Accured Expenses (2021 - 2026)

QuidelOrtho has disclosed Change in Accured Expenses across 6 years of filings, most recently posting -$17.9 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 65.51% year-over-year to -$17.9 million; the TTM figure through Jun 2026 stood at $40.0 million (down 25.79% YoY), while the FY2025 annual figure was $92.0 million, up 162.86% from the prior year.
• Change in Accured Expenses came in at -$17.9 million for Q2 2026 at QuidelOrtho, up from -$69.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $106.9 million in Q4 2025 to a low of -$101.2 million in Q1 2023.
• Average Change in Accured Expenses over 5 years is -$8.0 million, with a median of -$15.0 million recorded in 2022.
• The largest YoY upside for Change in Accured Expenses was 1364.38% in 2025 against a maximum downside of 774.03% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$12.2 million in 2022, then slumped by 87.7% to -$22.9 million in 2023, then surged by 131.88% to $7.3 million in 2024, then jumped by 1364.38% to $106.9 million in 2025, then slumped by 116.74% to -$17.9 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$17.9 million in Q2 2026, -$69.0 million in Q1 2026, and $106.9 million in Q4 2025.